Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial
Titel:
Nirmatrelvir–ritonavir versus placebo–ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial
Auteur:
Sawano, Mitsuaki Bhattacharjee, Bornali Caraballo, César Khera, Rohan Li, Shu-Xia Herrin, Jeph Christian, Dany Coppi, Andreas Warner, Frederick Holub, Julie Henriquez, Yashira Johnson, Maria A Goddard, Theresa B Rocco, Erica Hummel, Amy C Mouslmani, Mohammad AL Hooper, William Brenham Putrino, David F Carr, Kevin D Charnas, Lawrence De Jesus, Magdia Nepert, Dale Abreu, Paula Ziegler 3rd, Frank W Spertus, John A Iwasaki, Akiko Krumholz, Harlan M